ATLANTA, Georgia, Jan. 25 -- The American College of Rheumatology issued the following statement on Jan. 24, 2025: * * * The American College of Rheumatology (ACR) applauded the announcement of additional drugs subject to pricing negotiations with the Centers for Medicare & Medicaid Services (CMS). This second round includes nintedanib (Ofev) and apremilast (Otezla), which are used to treat common and rare rheumatologic conditions. "Excessive drug costs often create a financial burden for pat  more

WASHINGTON, Jan. 26 (TNSres) -- The Center for Strategic and International Studies issued the following report on January 24, 2025 by Gregory C. Allen, Georgia Adamson, Lennart Heim, and Sam Winter-Levy entitled "The United Arab Emirates' AI Ambitions." The United Arab Emirates (UAE) has placed a significant focus on becoming a leader in artificial intelligence (AI). This ambition is backed by substantial government funding and support from the country's leadership. The UAE aims to diversify it  more

ATLANTA, Georgia, Jan. 23 -- Emory University Rollins School of Public Health issued the following news release: Shortly after taking office on January 20, President Donald Trump signed a slew of executive orders that aim to do everything from withdrawing the United States from the World Health Organization to ending government diversity, equity, and inclusion programs. Many of the executive orders also seek to roll back climate protections established during the Biden administration. These ex  more